Therapeutic targeting of endometrial cancer with novel LIFR inhibitor EC359.

被引：0
|
作者：
Tang, Weiwei [1 ]
Ramasamy, Kumaraguruparan [1 ]
Pillai, Sureshkumar M. [1 ]
Santhamma, Bindu [2 ]
Konda, Swapna [2 ]
Vekata, Prabhakar P. [1 ]
Blankenship, Logan [1 ]
Liu, Junhao [1 ]
Liu, Zexuan [1 ]
Altwegg, Kristin A. [1 ]
Ebrahimi, Behnam [1 ]
Pratap, Uday P. [1 ]
Li, Xiaonan [1 ]
Kost, Edward [1 ]
Sareddy, Gangadhara R. [1 ]
Vadlamudi, Ratna K. [1 ]
Nair, Hareesh B. [1 ]
Tekmal, Rajeshwar R. [1 ]
Viswanadhapalli, Suryavathi [1 ]
机构：
[1] UT Hlth Sci Ctr San Antonio, San Antonio, TX USA
[2] Evestra, San Antonio, TX USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1253
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development of LIFR inhibitor EC359 as a novel therapeutic for ovarian cancer
    Viswanadhapalli, Suryavathi
    Nair, Hareesh B.
    Santhamma, Bindu
    Sareddy, Gangadhara R.
    Luo, Yiliao
    Pan, Xinlei
    Kost, Edward R.
    Murali, Ramachandran
    Tekmal, Rajeshwar Rao
    Nickisch, Klaus J.
    Vadlamudi, Ratna K.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [2] Targeting LIF/LIFR autocrine loops with EC359 in ovarian cancer: A novel LIFR targeted therapy
    Ebrahimi, Behnam
    Viswanadhapalli, Suryavathi
    Pratap, Uday P.
    Gopalam, Rahul
    Yang, Xue
    Santhamma, Bindhu
    Konda, Swapna
    Li, Xiaonan
    Yan, Hui
    Sareddy, Gangadhara R.
    Xu, Zhenming
    Kost, Edward R.
    Tekmal, Rajeshwar R.
    Nair, Hareesh B.
    Vadlamudi, Ratna K.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [3] The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling
    Spencer, Nicole
    Rodriguez Sanchez, Alondra Lee
    Gopalam, Rahul
    Subbarayalu, Panneerdoss
    Medina, Daisy M.
    Yang, Xue
    Ramirez, Paulina
    Randolph, Lois
    Aller, Emily Jean
    Santhamma, Bindu
    Rao, Manjeet K.
    Tekmal, Rajeshwar Rao
    Nair, Hareesh B.
    Kost, Edward R.
    Vadlamudi, Ratna K.
    Viswanadhapalli, Suryavathi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [4] Therapeutic utility of EC359 for targeting oncogenic LIFR signaling in triple negative breast cancer
    Viswanadhapalli, Suryavathi
    Li, Mengxing
    Luo, Yiliao
    Sareddy, Gangadhara R.
    Santhamma, Bindu
    Zhou, Mei
    Ma, Shihong
    Sonavane, Rajni
    Pratap, Uday P.
    Altwegg, Kristin A.
    Chang, Annabel
    Chavez-Riveros, Alejandra
    Dileep, Kalarickal V.
    Zhang, Kam Y.
    Bajda, Marek
    Raj, Ganesh V.
    Brenner, Andrew
    Manthati, Vijaya
    Rao, Manjeet
    Tekmal, Rajeshwar R.
    Nair, Hareesh B.
    Nickisch, Klaus J.
    Vadlamudi, Ratna K.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [5] LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
    Tang, Weiwei
    Ramasamy, Kumaraguruparan
    Pillai, Sureshkumar M. A.
    Santhamma, Bindu
    Konda, Swapna
    Venkata, Prabhakar Pitta
    Blankenship, Logan
    Liu, Junhao
    Liu, Zexuan
    Altwegg, Kristin A.
    Ebrahimi, Behnam
    Pratap, Uday P.
    Li, Xiaonan
    Valente, Philip T.
    Kost, Edward
    Sareddy, Gangadhara R.
    Vadlamudi, Ratna K.
    Nair, Hareesh B.
    Tekmal, Rajeshwar R.
    Viswanadhapalli, Suryavathi
    [J]. CELL DEATH DISCOVERY, 2021, 7 (01)
  • [6] LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
    Weiwei Tang
    Kumaraguruparan Ramasamy
    Sureshkumar M. A. Pillai
    Bindu Santhamma
    Swapna Konda
    Prabhakar Pitta Venkata
    Logan Blankenship
    Junhao Liu
    Zexuan Liu
    Kristin A. Altwegg
    Behnam Ebrahimi
    Uday P. Pratap
    Xiaonan Li
    Philip T. Valente
    Edward Kost
    Gangadhara R. Sareddy
    Ratna K. Vadlamudi
    Hareesh B. Nair
    Rajeshwar R. Tekmal
    Suryavathi Viswanadhapalli
    [J]. Cell Death Discovery, 7
  • [7] EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer
    Viswanadhapalli, Suryavathi
    Luo, Yiliao
    Sareddy, Gangadhara R.
    Santhamma, Bindu
    Zhou, Mei
    Li, Mengxing
    Ma, Shihong
    Sonavane, Rajni
    Pratap, Uday P.
    Altwegg, Kristin A.
    Li, Xiaonan
    Chang, Annabel
    Chavez-Riveros, Alejandra
    Dileep, Kalarickal, V
    Zhang, Kam Y. J.
    Pan, Xinlei
    Murali, Ramachandran
    Bajda, Marek
    Raj, Ganesh, V
    Brenner, Andrew J.
    Manthati, Vijaya
    Rao, Manjeet K.
    Tekmal, Rajeshwar R.
    Nair, Hareesh B.
    Nickisch, Klaus J.
    Vadlamudi, Ratna K.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (08) : 1341 - 1354
  • [8] The LIFR-targeting small molecules EC330/EC359 are potent ferroptosis inducers
    Feng, Chang-Zhou
    Li, Ning-Zhe
    Hu, Xi-Bo
    Xie, Yin -Yin
    Huang, Qiu-Hua
    Zhang, Jianming
    Chen, Zhu
    Chen, Sai-Juan
    Wang, Fudi
    Sun, Xiao-Jian
    [J]. GENES & DISEASES, 2023, 10 (03) : 735 - 738
  • [9] Development of a first-in-class small molecule inhibitor (EC359) targeting oncogenic LIF/LIFR signaling for the treatment of triple negative breast cancer
    Viswanadhapalli, S.
    Luo, Y.
    Sareddy, G. R.
    Santhamma, B.
    Zhou, M.
    Li, M.
    Pratap, U. P.
    Altwegg, K. A.
    Li, X.
    Srinivasan, U.
    Ma, S.
    Chang, A.
    Riveros, A. C.
    Zhang, K. Y.
    Dileep, K. V.
    Pan, X.
    Murali, R.
    Bajda, M.
    Raj, G.
    Brenner, A.
    Manthati, V.
    Rao, M.
    Tekmal, R. R.
    Nair, H. B.
    Nickisch, K. J.
    Vadlamudi, R. K.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [10] Targeting LIFR overcomes HDAC inhibitor resistance in ovarian cancer
    Li, Mengxing
    Viswanadhapalli, Suryavathi
    Sareddy, Gangadhara Reddy
    Santhamma, Bindu
    Yan, Hui
    Xu, Zhenming
    Kost, Edward
    Tekmal, Rajeshwar Rao
    Nair, Hareesh B.
    Nickisch, Klaus J.
    Vadlamudi, Ratna K.
    [J]. CANCER RESEARCH, 2019, 79 (13)
12345